By analogy, we packaged H19 into AAV9, AAV2-THGTPAD, and AAV2-NLPGSGD and injected mice 4 weeks after induction of TAC, i.e., when cardiac hypertrophy had already developed (Figure 8A). This evidence concerns the gene H19 and persistent truncus arteriosus.